CARTHY MARK

10% owner at Solexa, Inc. · on record since Jan 18, 2006
10% owner at Trubion Pharmaceuticals, Inc · on record since Oct 25, 2006
Director at Cyberkinetics Neurotechnology Systems, Inc. · on record since Oct 20, 2006
10% owner at Cyberkinetics Neurotechnology Systems, Inc. · on record since Oct 20, 2006
10% owner at ACADIA PHARMACEUTICALS INC · on record since May 26, 2004
Director at REXAHN PHARMACEUTICALS, INC. · on record since Mar 3, 2014
Director at Solexa, Inc. · on record since Mar 14, 2005

Insider trading activity of CARTHY MARK

Figures computed from official regulatory filings — methodology.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Company	Filed	Type	Qty	Price	Value · USD	Src
REXAHN PHARMACEUTICALS, INC.	Apr 12, 2017	AwardD	110,000	0.00 USD	$0	SEC
REXAHN PHARMACEUTICALS, INC.	Jun 10, 2016	AwardD	225,000	0.00 USD	$0	SEC
REXAHN PHARMACEUTICALS, INC.	Sep 18, 2015	AwardD	90,000	0.00 USD	$0	SEC
REXAHN PHARMACEUTICALS, INC.	Jun 11, 2014	AwardD	60,000	0.00 USD	$0	SEC
REXAHN PHARMACEUTICALS, INC.	Mar 3, 2014	AwardD	20,000	0.00 USD	$0	SEC
Solexa, Inc.	Jan 18, 2006	Award	279	10.74	$3K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
REXAHN PHARMACEUTICALS, INC.	Apr 12, 2017	AwardD	110,000	0.00 USD	$0	SEC
REXAHN PHARMACEUTICALS, INC.	Jun 10, 2016	AwardD	225,000	0.00 USD	$0	SEC
REXAHN PHARMACEUTICALS, INC.	Sep 18, 2015	AwardD	90,000	0.00 USD	$0	SEC
REXAHN PHARMACEUTICALS, INC.	Jun 11, 2014	AwardD	60,000	0.00 USD	$0	SEC
REXAHN PHARMACEUTICALS, INC.	Mar 3, 2014	AwardD	20,000	0.00 USD	$0	SEC
Solexa, Inc.	Jan 18, 2006	Award	279	10.74	$3K	SEC